Cite
MLA Citation
A. Harnden et al.. “Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo.” European journal of cancer, vol. 174, n.d., pp. S104–. http://access.bl.uk/ark:/81055/vdc_100168600408.0x000033